武晓秋
武晓秋,中国科学院杭州医学研究所副研究员。2021年博士毕业于香港浸会大学,2021年9月加入医学所,主要从事功能核酸筛选、膜蛋白互作研究、单细胞多维分子图谱绘制等方向的研究。研究成果以第一作者或通讯作者身份在《Journal of the American Chemical Society》,《Nature Reviews Bioengineering》,《Theranostics》,《Frontiers in Cell and Developmental Biology》,《Angewandte Chemie International Edition》, 《Science china chemistry》,《Talanta 》等期刊发表。
功能核酸筛选方法开发与单细胞多维分子图谱绘制
Xiaoqiu Wu1#, Xinrui Lin3#, Xiangqi Ma1, Huidong Huang1, Dengwei Zhang1, Yuqing Liu1, Rui Cheng3, Jia Song3, Lifei Zhang1, Yamin Tan1, Ruizi Peng1,2, Tao Bing1,4*, Qin Wu1*, Weihong Tan1,3* High-throughput Multiplexed Quantification of Molecules by Aptamer Sequencing (Apt-seq) in Single Cells. J Am Chem Soc. 2025;147(24):20394-20405.
Xiaoqiu Wu1#, Yuqing Liu1, Dengwei Zhang1, Jingjing Yu1, Mingxin Zhang1, Shuwei Feng1, Lifei Zhang1, Ting Fu1,2, Yamin Tan1, Tao Bing1, 3*, Weihong Tan1,6*. Efficient Strategy to Discover DNA Aptamers Against Low Abundance Cell Surface Proteins in Scarce Samples. J Am Chem Soc. 2024;146(39):26667-26675
Wu, Xiaoqiu, Honglin Liu, Dongmei Han, Bo Peng, Hui Zhang, Lin Zhang, Jianglin Li, Jing Liu, Cheng Cui, Senbiao Fang, Senbiao Fang, Mao Ye*, Weihong Tan*. "Elucidation and structural modeling of CD71 as a molecular target for cell-specific aptamer binding." Journal of the American Chemical Society 2019, 141(27):10760-10769.
Xiaoqiu Wu, Zilong Zhao, Huarong Bai, Ting Fu, Chao Yang, Xiaoxiao Hu, Qiaoling Liu, Carole Champanhac, I-Ting Teng, Mao Ye*, Weihong Tan*. DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition. Theranostics. 2015; 5(9): 985–994.
Dengwei Zhang, Yuqing Liu, Huidong Huang, Ting Fu, Tao Bing,* Xiaoqiu Wu,* and Weihong Tan* Streamlining RNA Aptamer Selection via Unique Molecular Identifiers and High-Throughput Sequencing. Analytical chemistry, 96(42), 16686–16694.
Long, Z., Feng, S., Xu, Y., Yu, J., Zhang, M., Wang, H., Jiang, D., Wang, L., Lin, H., Wu, X., Wang, H., & Bing, T. (2026)
Shilong Ying1,#, Hongli Chi1,#, Xiaoqiu Wu1,#, Pingping Zeng2, Jinling Chen1, Ting Fu1, Weitao Fu3, Penghui Zhang1,*, Weihong Tan1,4,5,*. Selective and orally bioavailable c-Met PROTACs for the treatment of c-Met-addicted cancer. Journal of medicinal chemistry, 67(19), 17053–17069.
Hong Kong PhD Fellowship,发明专利申请11项,授权3项。